Andreas Halvorsen started to build up the position in Esperion Therapeutics in Q1 2015 and continued to invest until Q2 2015. Since then they sold 1.4 Million shares. The investor sold all their shares in Q3 2015 and doesn't own any shares in Esperion Therapeutics anymore.